-
EP2185155
European procedure
Extract from the Register of European Patents
EP About this file: EP2185155
| EP2185155 - PHARMACEUTICAL COMPOSITIONS CONTAINING DOPAMINE RECEPTOR LIGANDS AND METHODS OF TREATMENT USING DOPAMINE RECPTOR LIGANDS [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 10.08.2018 Database last updated on 31.08.2024 | |
| Former | The patent has been granted Status updated on 01.09.2017 | ||
| Former | Grant of patent is intended Status updated on 30.03.2017 | ||
| Former | Examination is in progress Status updated on 27.01.2017 | Most recent event Tooltip | 10.08.2018 | No opposition filed within time limit | published on 12.09.2018 [2018/37] | Applicant(s) | For all designated states Richter Gedeon Nyrt. Gyömröi út 19-21. 1103 Budapest / HU | [2010/30] |
| Former [2010/20] | For all designated states Forest Laboratories Holdings Limited 18 Parliament Street Milner House Hamilton HM12 / BM | ||
| For all designated states Richter Gedeon Nyrt. Gyömröi út 19-21. 1103 Budapest / HU | Inventor(s) | 01 /
ADHAM, Nika 671 Summit Street Englewood Cliffs, NJ 07632 / US | 02 /
SAMORISKI, Gary 16 Estate Road Hillsborough, NJ 08844 / US | [2010/20] | Representative(s) | Hoffmann Eitle Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München / DE | [2017/40] |
| Former [2010/20] | HOFFMANN EITLE Patent- und Rechtsanwälte Arabellastraße 4 D-81925 München / DE | Application number, filing date | 08782602.0 | 04.08.2008 | [2010/20] | WO2008US72066 | Priority number, date | US20070953694P | 03.08.2007 Original published format: US 953694 P | [2010/20] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2009020897 | Date: | 12.02.2009 | Language: | EN | [2009/07] | Type: | A1 Application with search report | No.: | EP2185155 | Date: | 19.05.2010 | Language: | EN | The application published by WIPO in one of the EPO official languages on 12.02.2009 takes the place of the publication of the European patent application. | [2010/20] | Type: | B1 Patent specification | No.: | EP2185155 | Date: | 04.10.2017 | Language: | EN | [2017/40] | Search report(s) | International search report - published on: | US | 12.02.2009 | (Supplementary) European search report - dispatched on: | EP | 22.03.2012 | Classification | IPC: | A61K31/496, A61P25/24 | [2017/16] | CPC: |
A61K31/496 (EP,US);
A61K31/343 (EP,US);
A61K45/06 (EP,US);
A61P1/08 (EP);
A61P15/08 (EP);
A61P15/10 (EP);
A61P25/00 (EP);
A61P25/16 (EP);
A61P25/18 (EP);
A61P25/20 (EP);
A61P25/22 (EP);
A61P25/24 (EP);
| C-Set: |
A61K31/343, A61K2300/00 (EP,US);
A61K31/496, A61K2300/00 (US,EP) |
| Former IPC [2012/14] | A61K31/495, A61K31/551, A61P25/24 | ||
| Former IPC [2010/20] | A61K31/497, A61K31/4965 | Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR [2017/40] |
| Former [2010/20] | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR | Title | German: | PHARMAZEUTISCHE ZUSAMMENSETZUNGEN MIT DOPAMIN-REZEPTOR-LIGANDEN UND BEHANDLUNGSVERFAHREN MIT DOPAMIN-REZEPTOR-LIGANDEN | [2010/20] | English: | PHARMACEUTICAL COMPOSITIONS CONTAINING DOPAMINE RECEPTOR LIGANDS AND METHODS OF TREATMENT USING DOPAMINE RECPTOR LIGANDS | [2010/20] | French: | COMPOSITIONS PHARMACEUTIQUES CONTENANT DES LIGANDS DES RÉCEPTEURS DOPAMINERGIQUES ET PROCÉDÉ DE TRAITEMENT METTANT EN OEUVRE DES LIGANDS DES RÉCEPTEURS DE LA DOPAMINE | [2017/17] |
| Former [2010/20] | COMPOSITIONS PHARMACEUTIQUES CONTENANT DES LIGANDS DES RÉCEPTEURS DOPAMINERGIQUES ET PROCÉDÉ DE TRAITEMENT METTANT EN UVRE DES LIGANDS DES RÉCEPTEURS DE LA DOPAMINE | Entry into regional phase | 03.03.2010 | National basic fee paid | 03.03.2010 | Search fee paid | 03.03.2010 | Designation fee(s) paid | 03.03.2010 | Examination fee paid | Examination procedure | 03.03.2010 | Examination requested [2010/20] | 15.10.2012 | Amendment by applicant (claims and/or description) | 30.01.2017 | Despatch of a communication from the examining division (Time limit: M01) | 27.02.2017 | Reply to a communication from the examining division | 31.03.2017 | Communication of intention to grant the patent | 10.08.2017 | Fee for grant paid | 10.08.2017 | Fee for publishing/printing paid | 10.08.2017 | Receipt of the translation of the claim(s) | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 30.01.2017 | Opposition(s) | 05.07.2018 | No opposition filed within time limit [2018/37] | Fees paid | Renewal fee | 25.08.2010 | Renewal fee patent year 03 | 24.08.2011 | Renewal fee patent year 04 | 23.08.2012 | Renewal fee patent year 05 | 23.08.2013 | Renewal fee patent year 06 | 25.08.2014 | Renewal fee patent year 07 | 20.08.2015 | Renewal fee patent year 08 | 22.08.2016 | Renewal fee patent year 09 | 22.08.2017 | Renewal fee patent year 10 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [Y]WO2006082456 (RICHTER GEDEON VEGYESZET [HU], et al) [Y] 1-4 * abstract * * page 3, line 10 *; | [XDYI]US2006229297 (CSONGOR EVA A [HU], et al) [XD] 1 * abstract * * paragraph [0005] - paragraph [0011] * * paragraphs [0083] - [0085] * [Y] 1-4 [I] 2; | [E]WO2008139235 (RICHTER GEDEON NYRT [HU], et al) [E] 1-3 * abstract * * page 2, paragraph last - page 3, paragraph first *; | [Y] - HILLERT A ET AL, "Risperidone in the treatment of disorders with a combined psychotic and depressive syndrome--a functional approach.", PHARMACOPSYCHIATRY, (199209), vol. 25, no. 5, ISSN 0176-3679, pages 213 - 217, XP009156770 [Y] 1-4 * abstract * DOI: http://dx.doi.org/10.1055/s-2007-1014408 | [Y] - JANICAK PHILIP G ET AL, "Risperidone monotherapy versus risperidone or haloperidol plus sertraline for major depression with psychosis: Results of a pilot, double-blind, placebo-controlled trial", BIOLOGICAL PSYCHIATRY, ELSEVIER SCIENCE, NEW YORK, NY, US, (20060401), vol. 59, no. 8, Suppl, ISSN 0006-3223, page 146S, XP009156754 [Y] 1-4 * abstract * | [Y] - MATHEWS J ET AL, "Antidepressant efficacy of olanzapine as monotherapy in major depressive disorder, without psychosis: A pilot study", PSYCHIATRY RESEARCH: NEUROIMAGING, ELSEVIER, AMSTERDAM, NL, vol. 146, no. 2, doi:10.1016/J.PSCYCHRESNS.2005.08.003, ISSN 0925-4927, (20060331), pages 149 - 155, (20060331), XP027998411 [Y] 1-4 * abstract * DOI: http://dx.doi.org/10.1016/j.pscychresns.2005.08.003 | [Y] - GYERTYAN I ET AL, "P.3.d.006 Pharmacological profile of RGH-188, a novel dopamine D3/D2 receptor antagonist/partial agonist atypical antipsychotic", EUROPEAN NEUROPSYCHOPHARMACOLOGY, ELSEVIER SCIENCE PUBLISHERS BV, AMSTERDAM, NL, vol. 16, ISSN 0924-977X, (20060101), page S432, (20060101), XP027969902 [Y] 1-4 * abstract * | [Y] - Thomson Reuters Drug News (formerly DailyDrugNews.com), "Gedeon Richter signs new agreement for antipsychotic RGH-188", (20060516), Thomson Reuters Integrity, URL: https://integrity.thomson-pharma.com/integrity/xmlxsl/pk_ref_list.xml_show_ficha_ref?p_ref_id=990898, (20120222), XP002670062 [Y] 1-4 * abstract * | [Y] - PAPAKOSTAS ET AL, "Dopaminergic-based pharmacotherapies for depression", EUROPEAN NEUROPSYCHOPHARMACOLOGY, ELSEVIER SCIENCE PUBLISHERS BV, AMSTERDAM, NL, vol. 16, no. 6, doi:10.1016/J.EURONEURO.2005.12.002, ISSN 0924-977X, (20060801), pages 391 - 402, (20060801), XP025110892 [Y] 1-4 * abstract * * page 397, column l3, paragraph 3.2.2 * DOI: http://dx.doi.org/10.1016/j.euroneuro.2005.12.002 | International search | [Y]US7030122 (HAUSKE JAMES R [US], et al); | [Y]US2006229297 (CSONGOR EVA A [HU], et al); | [Y]US2007042014 (CREMERE THOMAS IVO F H [NL], et al); | [Y] - NUMBERG., "Managing Treatment-Emergent Sexual Dysfunction Associated with Serotogenic Antidepressants: Before and After Sildenafil", JOURNAL OF PSYCHIATRIC PRACTICE, (2001), vol. 7, page 98, XP008130700 |